The 3 and 5 year follow up of children who participated in the DOMInO study: growth and insulin resistance follow-up.

The 3 and 5 year follow up of children who participated in the DOMInO study: does maternal supplementation with n-3 long-chain PUFA in pregnancy influence child growth and insulin resistance?

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12611001127998

Acronym

The ChOIR Study

Enrollment

1531

Registered

2011-10-27

Start date

2009-03-25

Completion date

2013-10-04

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The primary aim of the study is to determine the effect of maternal dietary supplementation with n-3 LCPUFA in pregnancy on the percentage body fat in children at 3 and 5 years of age. the pathway to obesity begins early in life, and reducing this early accumulation of excess body fat represents an essential strategy for improving health outcomes across the life course.

Interventions

This study is a follow up from the original DOMInO Study: ACTRN12605000569606. 3 x 0.5 DHA rich Tuna Oil Capsules taken daily from 18-21 weeks until birth of child in The DOMInO Study.

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Prevention

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

3 Years to 5 Years

Healthy volunteers

Yes

Inclusion criteria

All children from the original DOMInO trial enrolled from the South Australian recruitment sites.

Exclusion criteria

nil

Outcome results